Yatsen Holding Limited

Yatsen Holding Limited Earnings Recaps

YSG Consumer Discretionary 4 recaps
Next earnings: November 24, 2026 (estimated) · full calendar
Q2 2026 Sep 4, 2026

Shares dropped 11.2% after Yatsen’s results revealed margin pressure from inventory provisions in color cosmetics and deceleration in overall revenue growth, disappointing investors who likely expected steadier profitability and clearer improvement in the struggling segment.

Key takeaways
  • Total net revenue grew a modest 5.1% year over year, falling short of prior expectations amid industry headwinds.
  • Skincare revenue remained a bright spot with a strong 40.4% increase, now accounting for 71.5% of total sales and driving the company’s strategic shift.
  • Gross margin was negatively impacted by higher inventory provisions related to proactive SKU rationalization and portfolio optimization in the color cosmetics segment.
  • Selling and marketing expenses increased as a percentage of revenue, driven by investments in high-growth channels such as Douyin.
  • Management highlighted ongoing challenges in color cosmetics due to fast-changing trends and intense promotional activity, with efforts underway to streamline the portfolio and improve profitability.
Q1 2026 May 27, 2026

Yatsen’s shares gained 3.9% following a quarter marked by strong top-line growth and margin expansion, driven primarily by impressive skincare brand performance that outpaced market growth.

Key takeaways
  • Total net revenues rose 22.5% year-over-year to RMB 1.02 billion, supported by a 58.5% surge in skincare brand sales.
  • Gross margin expanded to 18.2%, hitting a historic high and indicating improved operational leverage.
  • R&D investment increased to 3.9% of net revenues, underpinning innovation-led growth with multiple new product launches.
  • Selling and marketing expenses rose due to brand-building initiatives and higher online traffic acquisition costs, reflecting a deliberate investment in long-term positioning.
  • Management emphasized ongoing efforts to optimize profitability through dynamic channel mix adjustments and cost control measures.
Q3 2025 Nov 17, 2025

Yatsen Holding Limited reported a robust 47.5% year-over-year growth in total net revenues for Q3 2025, marking its fourth consecutive quarter of revenue growth and significantly narrowing its net loss margin.

Key takeaways
  • Skincare brands experienced exceptional growth of 83.2%, accounting for 49.2% of total revenue, underscoring a successful category upgrade strategy.
  • The net loss margin improved from 17.9% to 7%, reflecting enhanced gross margins and operational efficiencies.
  • Continued emphasis on innovation led to successful product launches and increased customer engagement, particularly in the Galani and Doctor Wu brands.
  • Yatsen remains focused on disciplined capital allocation while driving profitability through a balanced growth strategy in its brand portfolio.
Q2 2025 Aug 21, 2025

Yatsen delivered a strong second quarter of 2025 with revenue growth of 36.8% year-over-year, driven by a remarkable recovery in its skincare segment and strategic R&D initiatives.

Key takeaways
  • Total net revenues reached RMB 1.09 billion, significantly surpassing prior guidance.
  • Skincare revenues surged 78.7%, bolstered by the performance of flagship brands like Galénic and DR.WU.
  • The company achieved its third consecutive quarter of non-GAAP profitability, with a net loss margin reduced to 1.8% from 10.8% year-over-year.
  • Innovations in color cosmetics, particularly from Perfect Diary, contributed to renewed growth, with a focus on "makeup skinification."
  • Yatsen continued to enhance its R&D capabilities, reinforcing its commitment to product innovation and brand equity.